-
Detailed Analysis Generate Full Report Add to Watchlist
Values as of: 2025-04-01
ALC:NYE- (USD)
COMMON STOCK | Medical Instruments & Supplies |
Last Closing
USD 92.7Change
-2.23 (-2.35)%Market Cap
USD 46.01BVolume
2.03MVerdict
Verdict
Values as of: 2025-04-01
COMMON STOCK | Medical Instruments & Supplies |
Last Closing
USD 92.7Change
-2.23 (-2.35)%Market Cap
USD 46.01BVolume
2.03MVerdict
Verdict
Currency: USD
Country : USA
Symbol | Name | Price(Change) | Market Cap |
---|---|---|---|
BDX | Becton Dickinson and Company |
+0.38 (+0.17%) |
USD 65.91B |
RMD | ResMed Inc |
+0.70 (+0.31%) |
USD 34.14B |
BAX | Baxter International Inc |
-0.37 (-1.09%) |
USD 18.71B |
AVTR | Avantor Inc |
+0.49 (+3.10%) |
USD 11.92B |
ATR | AptarGroup Inc |
+1.43 (+0.96%) |
USD 10.16B |
TFX | Teleflex Incorporated |
+1.08 (+0.77%) |
USD 6.39B |
STVN | Stevanato Group SpA |
+0.09 (+0.43%) |
USD 5.88B |
BLCO | Bausch + Lomb Corp |
+0.25 (+1.77%) |
USD 5.64B |
WRBY | Warby Parker Inc |
-0.04 (-0.22%) |
USD 2.55B |
INFU | InfuSystems Holdings Inc |
-0.04 (-0.75%) |
USD 0.13B |
Symbol | Name | Weight | Mer | Price(Change) | Market Cap |
---|---|---|---|---|---|
CHSR:XETRA | UBS(Lux)Fund Solutions .. | 5.08 % | 0.00 % |
-0.14 (-1.22%) |
USD 0.17B |
CHSRI:SW | UBS ETF (CH) - MSCI Switz.. | 5.01 % | 0.00 % |
-0.16 (-1.22%) |
N/A |
CHSRIA:SW | UBS ETF (CH) MSCI Switzer.. | 5.01 % | 0.00 % |
-0.16 (-1.22%) |
N/A |
CHSRII:SW | UBS(Lux)Fund Solutions .. | 4.98 % | 0.00 % |
-0.11 (-1.22%) |
N/A |
SLICHA:SW | UBS ETF (CH) – SLI® (C.. | 4.34 % | 0.00 % |
-1.75 (-1.22%) |
USD 32,912.73B |
XSLI:SW | Xtrackers SLI UCITS ETF 1.. | 4.34 % | 0.00 % |
-1.05 (-1.22%) |
USD 0.31B |
CSSLI:SW | iShares SLI® ETF (CH) | 4.34 % | 0.00 % |
-1.95 (-1.22%) |
USD 0.67B |
SMIEX:SW | iShares SLI UCITS ETF (DE.. | 4.32 % | 0.00 % |
-1.62 (-1.22%) |
USD 5,933.96B |
CBCH30:SW | 3.78 % | 0.00 % |
N/A |
N/A | |
XSMI:XETRA | Xtrackers Switzerland UCI.. | 3.15 % | 0.00 % |
-1.66 (-1.22%) |
N/A |
ESRU:LSE | Amundi Index Solutions - .. | 3.12 % | 0.00 % |
-0.03 (-1.22%) |
N/A |
ACU7:XETRA | Amundi Index Solutions - .. | 3.11 % | 0.00 % |
-0.26 (-1.22%) |
USD 0.13B |
ESDU:LSE | Amundi Index Solutions - .. | 3.09 % | 0.00 % |
N/A |
N/A |
XSMC:SW | Xtrackers Switzerland UCI.. | 3.05 % | 0.00 % |
-1.42 (-1.22%) |
USD 0.51B |
XSMI:SW | Xtrackers Switzerland UCI.. | 3.05 % | 0.00 % |
-1.16 (-1.22%) |
USD 1.36B |
CSSMI:SW | iShares SMI® ETF (CH) | 3.04 % | 0.00 % |
-1.28 (-1.22%) |
USD 2.16B |
SMICHA:SW | UBS ETF (CH) – SMI® (C.. | 3.04 % | 0.00 % |
-1.02 (-1.22%) |
USD 17,142.72B |
CHEUR:SW | UBS(Lux)Fund Solutions .. | 2.79 % | 0.00 % |
N/A |
N/A |
CHEURD:SW | UBS(Lux)Fund Solutions .. | 2.79 % | 0.00 % |
N/A |
N/A |
CHUSD:SW | UBS(Lux)Fund Solutions .. | 2.79 % | 0.00 % |
-0.07 (-1.22%) |
N/A |
CHUSDD:SW | UBS(Lux)Fund Solutions .. | 2.79 % | 0.00 % |
N/A |
N/A |
SWEUAH:SW | UBS ETF (CH) – MSCI Swi.. | 2.70 % | 0.00 % |
N/A |
USD 226,274.20B |
SWUSAH:SW | UBS ETF (CH) – MSCI Swi.. | 2.70 % | 0.00 % |
-0.25 (-1.22%) |
USD 226,274.21B |
SWICHA:SW | UBS ETF (CH) – MSCI Swi.. | 2.70 % | 0.00 % |
-0.15 (-1.22%) |
USD 226,274.25B |
SW2CHA:SW | UBS(Lux)Fund Solutions .. | 2.68 % | 0.00 % |
-0.28 (-1.22%) |
USD 0.49B |
SW2CHB:SW | UBS(Lux)Fund Solutions .. | 2.68 % | 0.00 % |
-0.22 (-1.22%) |
USD 1.76B |
SW2UKD:SW | UBS(Lux)Fund Solutions .. | 2.68 % | 0.00 % |
-0.10 (-1.22%) |
USD 0.04B |
S2HGBD:SW | UBS(Lux)Fund Solutions .. | 2.68 % | 0.00 % |
N/A |
USD 0.07B |
S2HGBA:SW | UBS(Lux)Fund Solutions .. | 2.68 % | 0.00 % |
N/A |
USD 8.29M |
STWX:SW | SPDR® MSCI Europe Health.. | 2.62 % | 0.00 % |
-3.30 (-1.22%) |
USD 0.66B |
ESRG:LSE | Amundi Index Solutions - .. | 2.60 % | 0.00 % |
N/A |
USD 2.03B |
ESDG:LSE | Amundi Index Solutions - .. | 2.60 % | 0.00 % |
-15.50 (-1.22%) |
USD 0.19B |
SXDPEX:SW | iShares STOXX Europe 600 .. | 2.54 % | 0.00 % |
N/A |
USD 0.44B |
HEAE:LSE | SPDR® MSCI Europe Health.. | 2.50 % | 0.00 % |
-3.17 (-1.22%) |
N/A |
SPICHA:SW | UBS ETF (CH) – SPI® (C.. | 2.46 % | 0.00 % |
-0.71 (-1.22%) |
USD 131,872.43B |
ASRP:XETRA | BNP Paribas Easy ECPI Glo.. | 2.26 % | 0.00 % |
-0.08 (-1.22%) |
N/A |
MTUSD:PA | BNP Paribas Easy ECPI Glo.. | 2.16 % | 0.00 % |
-0.14 (-1.22%) |
N/A |
MEDTE:PA | BNP Paribas Easy ECPI Glo.. | 2.10 % | 0.00 % |
-0.10 (-1.22%) |
N/A |
VLED:SW | BNP Paribas Easy ESG Equi.. | 2.07 % | 0.00 % |
N/A |
USD 5.68M |
EWL | iShares MSCI Switzerland .. | 0.00 % | 0.47 % |
-0.27 (-1.22%) |
N/A |
LNGR | 0.00 % | 0.50 % |
N/A |
N/A | |
RNDM | 0.00 % | 0.65 % |
N/A |
N/A | |
FLSW | Franklin FTSE Switzerland.. | 0.00 % | 0.09 % |
-0.21 (-1.22%) |
USD 0.06B |
HLTH:LSE | SPDR® MSCI Europe Health.. | 0.00 % | 0.00 % |
-3.95 (-1.22%) |
N/A |
XSDR:LSE | Xtrackers MSCI Europe Hea.. | 0.00 % | 0.00 % |
-335.00 (-1.22%) |
USD 0.23B |
UC93:LSE | UBS MSCI Switzerland 20/3.. | 0.00 % | 0.00 % |
-20.25 (-1.22%) |
USD 8.21M |
UC94:LSE | UBS(Lux)Fund Solutions .. | 0.00 % | 0.00 % |
-17.25 (-1.22%) |
USD 0.07B |
EUSRI:PA | Amundi Index Solutions - .. | 0.00 % | 0.00 % |
-0.20 (-1.22%) |
USD 2.00B |
EVOE:PA | BNP Paribas Easy ESG Equi.. | 0.00 % | 0.00 % |
-0.24 (-1.22%) |
USD 0.06B |
STW:PA | SPDR® MSCI Europe Health.. | 0.00 % | 0.00 % |
-3.95 (-1.22%) |
USD 0.72B |
VLED:PA | BNP Paribas Easy ESG Equi.. | 0.00 % | 0.00 % |
-0.50 (-1.22%) |
USD 5.76M |
C030:F | Lyxor DJ Switzerland Tita.. | 0.00 % | 0.00 % |
N/A |
USD 0.01B |
DBXS:F | 0.00 % | 0.00 % |
N/A |
N/A | |
DXS0:F | Xtrackers - SLI UCITS ETF | 0.00 % | 0.00 % |
N/A |
N/A |
DXSE:F | Xtrackers Stoxx Europe 60.. | 0.00 % | 0.00 % |
N/A |
N/A |
EL4X:F | Deka DAXplus Maximum Divi.. | 0.00 % | 0.00 % |
N/A |
N/A |
EXI1:F | iShares SLI UCITS ETF (DE.. | 0.00 % | 0.00 % |
N/A |
N/A |
EXV4:F | 0.00 % | 0.00 % |
N/A |
N/A | |
EXV5:F | 0.00 % | 0.00 % |
N/A |
N/A | |
MIVB:F | Amundi Index Solutions - .. | 0.00 % | 0.00 % |
+0.46 (+-1.22%) |
N/A |
SPYH:F | SSgA SPDR ETFs Europe II .. | 0.00 % | 0.00 % |
N/A |
N/A |
VLED:F | BNP Paribas Easy - Equity.. | 0.00 % | 0.00 % |
-0.32 (-1.22%) |
USD 0.07B |
VLEU:F | BNP Paribas Easy - Equity.. | 0.00 % | 0.00 % |
N/A |
USD 0.05B |
C030:XETRA | Amundi Index Solutions - .. | 0.00 % | 0.00 % |
-2.14 (-1.22%) |
USD 0.13B |
DBXS:XETRA | Xtrackers - Switzerland U.. | 0.00 % | 0.00 % |
-1.66 (-1.22%) |
USD 1.34B |
DXS0:XETRA | Xtrackers SLI UCITS ETF 1.. | 0.00 % | 0.00 % |
-2.40 (-1.22%) |
USD 0.26B |
DXSE:XETRA | Xtrackers - Stoxx Europe .. | 0.00 % | 0.00 % |
-3.25 (-1.22%) |
USD 0.14B |
EXI1:XETRA | iShares SLI UCITS ETF (DE.. | 0.00 % | 0.00 % |
-1.66 (-1.22%) |
USD 0.37B |
EXV4:XETRA | iShares STOXX Europe 600 .. | 0.00 % | 0.00 % |
-1.96 (-1.22%) |
USD 0.70B |
MIVB:XETRA | Amundi Index Solutions - .. | 0.00 % | 0.00 % |
-0.31 (-1.22%) |
N/A |
SPYH:XETRA | SPDR® MSCI Europe Health.. | 0.00 % | 0.00 % |
-3.75 (-1.22%) |
N/A |
1391:TSE | 0.00 % | 0.00 % |
N/A |
N/A | |
CHSPI:SW | iShares Core SPI® ETF (C.. | 0.00 % | 0.00 % |
-0.96 (-1.22%) |
USD 4.06B |
CEFA | Global X S&P Catholic Val.. | 0.00 % | 0.00 % |
+0.20 (+-1.22%) |
USD 0.02B |
ESIH:LSE | iShares MSCI Europe Healt.. | 0.00 % | 0.00 % |
-0.10 (-1.22%) |
USD 0.83B |
ESIH:F | Ishares VI PLC - Ishares .. | 0.00 % | 0.00 % |
-0.10 (-1.22%) |
N/A |
ESIH:XETRA | iShares MSCI Europe Healt.. | 0.00 % | 0.00 % |
-0.14 (-1.22%) |
N/A |
CHDIV:SW | UBS ETF (CH) - MSCI Switz.. | 0.00 % | 0.00 % |
-0.09 (-1.22%) |
USD 1,244,681.59B |
Market Performance vs. Industry/Classification (Medical Instruments & Supplies) | Market Performance vs. Exchange | ||||||
Value | Sector Median | Percentile Rank | Grade | Market Median | Percentile Rank | Grade | |
YTD | |||||||
Capital Gain | 9.20% | 94% | A | 88% | B+ | ||
Dividend Return | N/A | N/A | N/A | N/A | N/A | ||
Total Return | 9.20% | 94% | A | 87% | B+ | ||
Trailing 12 Months | |||||||
Capital Gain | 13.46% | 83% | B | 82% | B | ||
Dividend Return | 0.32% | 33% | F | 4% | F | ||
Total Return | 13.79% | 83% | B | 79% | B- | ||
Trailing 5 Years | |||||||
Capital Gain | 87.16% | 93% | A | 62% | D | ||
Dividend Return | N/A | N/A | N/A | N/A | N/A | ||
Total Return | 87.16% | 93% | A | 53% | F | ||
Average Annual (5 Year Horizon) | |||||||
Capital Gain | 11.06% | 90% | A- | 69% | C- | ||
Dividend Return | 11.34% | 90% | A- | 64% | D | ||
Total Return | 0.27% | 42% | F | 8% | B- | ||
Risk Return Profile | |||||||
Volatility (Standard Deviation) | 16.78% | 90% | A- | 61% | D- | ||
Risk Adjusted Return | 67.55% | 100% | F | 78% | C+ | ||
Market Capitalization | 46.01B | 93% | A | 95% | A |
Target Price Action | Rating Action | Analyst | Rating | Price | Date |
---|
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.
The company is less leveraged than its peers ,, and is among the top quartile, which makes it more flexible. However, do check the news and look at its sector. Sometimes this is low because the company is not growing and has no growth potential.
The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.
This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.
The company had positive total cash flow in the most recent four quarters.
The company had positive total free cash flow in the most recent four quarters.
This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.
The company management has delivered below median return on assets in the most recent 4 quarters compared to its peers.
The company management has delivered below median return on invested capital in the most recent 4 quarters compared to its peers.
The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
The company has under performed its peers on annual average total returns in the past 5 years.
The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
This stock has shown below median dividend growth in the previous 5 years compared to its sector.